Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
53.92%
operating margin TTM
42.85%
revenue TTM
53.06 Million
revenue per share TTM
1.8$
valuation ratios | |
|---|---|
| pe ratio | 38.56 |
| peg ratio | 0.48 |
| price to book ratio | 6.80 |
| price to sales ratio | 20.93 |
| enterprise value multiple | 49.79 |
| price fair value | 6.80 |
profitability ratios | |
|---|---|
| gross profit margin | 92.79% |
| operating profit margin | 42.85% |
| pretax profit margin | 49.68% |
| net profit margin | 53.92% |
| return on assets | 16.11% |
| return on equity | 19.25% |
| return on capital employed | 13.87% |
liquidity ratios | |
|---|---|
| current ratio | 9.46 |
| quick ratio | 9.06 |
| cash ratio | 4.65 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 517.69 |
| operating cycle | 628.79 |
| days of payables outstanding | 49.64 |
| cash conversion cycle | 579.15 |
| receivables turnover | 3.29 |
| payables turnover | 7.35 |
| inventory turnover | 0.71 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 139.04 |
cash flow ratios | |
|---|---|
| free cash flow per share | 8.11 |
| cash per share | 28.11 |
| operating cash flow per share | 8.55 |
| free cash flow operating cash flow ratio | 0.95 |
| cash flow coverage ratios | 139.04 |
| short term coverage ratios | 139.04 |
| capital expenditure coverage ratio | 19.41 |
Frequently Asked Questions
When was the last time Krystal Biotech, Inc. (NASDAQ:KRYS) reported earnings?
Krystal Biotech, Inc. (KRYS) published its most recent earnings results on 04-05-2026.
What is Krystal Biotech, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Krystal Biotech, Inc. (NASDAQ:KRYS)'s trailing twelve months ROE is 19.25%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Krystal Biotech, Inc. (KRYS) currently has a ROA of 16.11%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KRYS's net profit margin stand at?
KRYS reported a profit margin of 53.92% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KRYS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 9.46 in the most recent quarter. The quick ratio stood at 9.06, with a Debt/Eq ratio of 0.00.